Andrew Last
Equibles does not estimate personal net worth.
About Andrew Last
Earlier roles on record: COO at Bio-Rad Laboratories, Inc. (BIO) until September 5, 2024. Bio-Rad Laboratories, Inc. reported in an 8-K filed August 20, 2024 that Andrew Last retired as Executive Vice President, Chief Operating Officer (and principal operating officer), effective September 5, 2024. The proxy statement of Bio-Rad Laboratories, Inc. reports total compensation of $3,270,089 for Andrew Last in fiscal 2023, including a base salary of $660,250. Disclosed compensation is on record for 5 fiscal years. Andrew Last has spoken on 8 earnings calls across 1 company, most recently for Bio-Rad Laboratories, Inc. on May 7, 2024. The companies whose calls Andrew Last spoke on are classified in the Healthcare sector.
“Dr. Last will be retiring from his position on September 5, 2024.”
Andrew Last on recent calls
“The first quarter of 2024 reflected a continuation of the same macroeconomic and market trends we experienced in 2023 in the Biotech and Biopharma segments as well as China and Russia.”
“So as we look at 2023 revenue overall, let me just break it down between the two business areas. So, overall, I would say the strategic drivers of revenue growth remain consistent with our digital PCR platform, process chromatographic continued growth in that platform area.”
“So yes, I think we mentioned in the script that we're already seeing it easing. We were more constrained at the beginning of the quarter than as we came out of the quarter and now entering into Q4, we see our production improving.”
“I want to acknowledge the incredible contributions, resilience, and responsiveness of all our employees worldwide as we concluded another challenging year of the pandemic.”
“So to parse the question first, progress is going very well. I would say we're on track with our expectations. So thinking of contributions to operating performance, it really is a delayed effect.”
Affiliation history
-
Start not stated–2024-09-05
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President Chief Operating Officer | $660,250 | $3,270,089 |
| 2022 | Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President Chief Operating Officer | $638,566 | $3,366,135 |
| 2021 | Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President Chief Operating Officer | $610,760 | $4,211,413 |
| 2020 | Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President Chief Operating Officer | $612,346 | $3,924,152 |
| 2019 | Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President Chief Operating Officer | $387,019 | $2,734,761 |